Literature DB >> 27538601

Psychogenic non-epileptic seizures and functional motor symptoms: A common phenomenology?

Benedetta Demartini1, Diana Goeta2, Valentina Barbieri2, Lucia Ricciardi3, Maria Paola Canevini4, Katherine Turner4, Armando D'Agostino2, Luigi Romito5, Orsola Gambini2.   

Abstract

OBJECTIVE: Recent studies have attempted to compare patients affected by psychogenic non-epileptic seizures (PNES) to patients affected by functional motor symptoms (FMS) from a demographic, clinical and psychological perspective. Nevertheless, results are quite controversial and significant conclusions have not been drawn. The aim of our study was to evaluate the phenomenology of psychology of the two groups assessing levels of dissociation and its subcomponents, alexithymia and interoceptive sensitivity in patients with PNES and in patients with FMS.
METHODS: We conducted a cross-sectional study recruiting 20 patients with PNES, 20 patients with FMS and 20 healthy subjects as a control group. All subjects underwent: Dissociative Experience Scale (DES), Somatoform Dissociation Questionnaire (SDQ-20), Cambridge Depersonalization Scale (CDS), Toronto Alexithymia Scale (TAS-20), Hamilton Rating Scale for Depression (HAM-D), Hamilton Rating Scale for anxiety (HAM-A), heart beat detection task.
RESULTS: Our data suggest that PNES group scored significantly higher than the healthy control group on a measure of detachment (CDS). Also at the DES, a measure of psychoform dissociation, PNES patients scored significantly higher than healthy subjects. On the other hand patients affected by FMS scored significantly higher than the healthy control group on the SDQ but they did not report more experiences of detachment on the CDS. Patients affected by PNES and FMS were significantly more alexithymic than healthy controls, with a third of them scoring >61 on the TAS-20. SIGNIFICANCE: Our data show different psychological mechanisms underlying patients with PNES and patients with FMS. This might lead also to potential implications for treatment.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27538601     DOI: 10.1016/j.jns.2016.06.045

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

Review 1.  A review of functional neurological symptom disorder etiology and the integrated etiological summary model

Authors:  Aaron D. Fobian; Lindsey Elliott
Journal:  J Psychiatry Neurosci       Date:  2019-01-01       Impact factor: 6.186

2.  Autonomic, Endocrine, and Inflammation Profiles in Functional Neurological Disorder: A Systematic Review and Meta-Analysis.

Authors:  Sara Paredes-Echeverri; Julie Maggio; Indrit Bègue; Susannah Pick; Timothy R Nicholson; David L Perez
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2021-10-29       Impact factor: 2.198

3.  Are Functional (Psychogenic Nonepileptic) Seizures the Sole Expression of Psychological Processes?

Authors:  Petr Sojka; Sara Paredes-Echeverri; David L Perez
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 4.  Subjective versus objective measures of distress, arousal and symptom burden in patients with functional seizures and other functional neurological symptom disorder presentations: A systematic review.

Authors:  Joy Adewusi; Liat Levita; Cordelia Gray; Markus Reuber
Journal:  Epilepsy Behav Rep       Date:  2021-11-09

5.  Interoceptive accuracy and bias in somatic symptom disorder, illness anxiety disorder, and functional syndromes: A systematic review and meta-analysis.

Authors:  Carolin Wolters; Alexander L Gerlach; Anna Pohl
Journal:  PLoS One       Date:  2022-08-18       Impact factor: 3.752

6.  Trait and state interoceptive abnormalities are associated with dissociation and seizure frequency in patients with functional seizures.

Authors:  Akihiro Koreki; Sarah N Garfkinel; Marco Mula; Niruj Agrawal; Sarah Cope; Talia Eilon; Cassandra Gould Van Praag; Hugo D Critchley; Mark Edwards; Mahinda Yogarajah
Journal:  Epilepsia       Date:  2020-06-05       Impact factor: 6.740

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.